The Innovative Force Driving the Future of Regenerative Medicine
Pioneering Biomimetic Regeneration: Our Journey and Commitment
Mission: Committed to overcoming the major challenges of soft tissue defect repair through pioneering biomimetic regenerative material technology, bringing the hope of functional reconstruction and a higher quality of life to patients around the world.
Vision: To contribute to regenerative medicine, spearheading the future development of tissue engineering with continuous scientific innovation and excellent product transformation, letting regeneration give life infinite possibilities.
Our Philosophy: We firmly believe that a patient-centered approach, an unwavering innovative spirit, and scientific rigor are the cornerstones of realizing this grand blueprint.
Our Core Team & Founder
Our core team comprises experts with profound academic backgrounds and rich R&D experience in regenerative medicine, biomaterials science, collagen research, tissue engineering, and clinical medicine.
Dr. Xiaoming He (Main Research Leader): PhD from Chiba University. He has dedicated over 20 years to regenerative medicine research at prestigious institutions including Hokkaido University, the National Institute for Materials Science (NIMS), and the University of Tokyo. Dr. He has participated in numerous major scientific research projects, achieved a series of remarkable research results, and published many high-level papers in international authoritative journals.
Team Strength: The team's interdisciplinary collaboration ability and keen insight into cutting-edge technology are the driving force for us to continuously achieve technological breakthroughs.
R&D Strength & Innovation Cornerstone
Platform & Facilities: We have built an international first-class biological materials R&D platform, covering the full-chain research capabilities from material design, synthesis, purification, characterization to biological evaluation (in vitro cell experiments, in vivo animal model experiments).
Technological Expertise: Especially in the extraction and purification of soluble collagen, biomimetic structure construction, and research on the interaction mechanism between materials and cells, we have unique core technology and process know-how.
Innovation: Innovation is the soul of our development. At present, we have a number of key technologies around the biomimetic regenerative material, forming a preliminary intellectual property protection system. Many papers detailing our research results have been published on preprint platforms such as mediRxiv, bioRxiv, fully demonstrating the vitality of our scientific research and the transparency of our achievements. We foster a team culture that pursues excellence, has the courage to explore, and seeks scientific verification, encouraging continuous innovation to ensure that technology is always at the forefront of the industry.
He, X., Luo, Z., He, S., & Jin, W. (2025a). Revolutionary high-performance soluble collagen-based surgical sutures: The next generation tissue healing technology. medRxiv. https://doi.org/10.1101/2025.05.19.25325989.[preprint]
He, X., Luo, Z., &He, S. (2025b) Breaking the Tendon Repair Barrier: A Biomimetic Soluble Collagen Scaffold Enables Full Functional Regeneration of Achilles Tendon in Rabbits. BioRxiv.https://doi.org/10.1101/2025.05.30.655895
He, X., Luo, Z., &He, S. (2025c) Breakthrough in Functional Muscle Regeneration: Biomimetic Collagen Scaffold Restores Abdominal Wall Defects in a VML-rabbit Models. BioRxiv. https://doi.org/10.1101/2025.06.07.657281
He, X., Luo, Z., &He, S. (2025d) Clinical breakthrough: Biomimetic Scaffolds Based on Soluble Collagen for Regenerating Large Volumes of Highly Functional Tissues. BioRxiv. https://doi.org/10.1101/2025.06.19.660623
Contact Email: xiaomhe@acarah.com
Our Promise
- Commitment to Science: We adhere to rigorous scientific research methods to ensure the safety and effectiveness of all technologies and products, and pursue true and reliable experimental data and clinical evidence.
- Commitment to Life: We have always aimed to improve human health and quality of life, and are committed to developing innovative medical programs that can truly solve clinical pain points and benefit the majority of patients.
- Commitment to Partners: We adhere to the principles of integrity, transparency and win-win cooperation, and look forward to working with global investors, industry partners and scientific researchers to promote the progress of regenerative medicine.